Cowen Investment Management’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History

Cowen Investment Management’s Portfolio FLACU Stock Details FLACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-40,000	Closed	-$400K	–	292
2022 Q1	$400K	Hold	40,000	–	–	0.09%	252
2021 Q4	$397K	Hold	40,000	–	–	0.09%	222
2021 Q3	$401	Hold	40,000	–	–	﹤0.01%	190
2021 Q2	$402K	Hold	40,000	–	–	0.1%	170
2021 Q1	$406K	Sell	40,000 -10,000	-20%	-$107K	0.16%	147
2020 Q4	$519K	Buy	+50,000	New	+$522K	0.24%	130

Other funds holding FLACU

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

MTCM

Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 18.84% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

Cowen Investment Management's FLACU Position: Q2 2022 in Review

Cowen Investment Management sold out of Frazier Lifesciences Acquisition Corporation Unit (FLACU) in Q2 2022, closing a stake of 40,000 shares — an estimated $400K sold.

Cowen Investment Management first reported a position in FLACU in Q4 2020 and held it in 6 quarters. The position peaked at $519K in Q4 2020. 17 funds tracked by Wall St. Rank hold FLACU as of Q2 2022.

Cowen Investment Management reported no remaining Frazier Lifesciences Acquisition Corporation Unit position as of Q2 2022 after selling out during the quarter.
Cowen Investment Management sold 40,000 Frazier Lifesciences Acquisition Corporation Unit shares in Q2 2022, an estimated $400K.
Cowen Investment Management first reported a position in Frazier Lifesciences Acquisition Corporation Unit in Q4 2020 and held it in 6 quarters.
Cowen Investment Management's Frazier Lifesciences Acquisition Corporation Unit position peaked at $519K in Q4 2020.
17 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Unit as of Q2 2022.

Based on Cowen Investment Management's 13F filing for Q2 2022, filed 9 Aug 2022.